Eurovet Animal Health has launched a new product, Bovocycline 2000 mg pessary for cattle.
Bovocycline 2000 is the only veterinary licenced antibiotic pessary for the treatment of retained foetal membranes in cattle. It is licenced for the treatment of post parturient disorders in cattle, for administration after dystocia, retained foetal membranes (RFMs) and endometritis.
According to Eurovet, the incidence of retained foetal membranes in cows varies from zero to 25 per cent, but the average is around 4 per cent in most herds. RFMs result in reduced cow fertility and a higher risk of culling due to poor fertility. Pessaries are still considered the preferred treatment for vulval discharges in cattle by farmers.
Ruth Vernon, Technical Services Manager for Eurovet said: "The control of post partum problems in cattle is rarely straight forward, but it is great to have a veterinary licensed treatment designed specifically for this purpose, in one pessary that contains 2000mgs tetracycline".
For more information please contact Eurovet Animal Health. Tel: 01223 257933. E-mail: office@eurovet-ah.co.uk www.eurovet-ah.co.uk
Severn Edge was formed six years ago with the merger of two long-standing neighbouring practices, and now employs 135 people, including 43 veterinary surgeons.
Mrs Karyn MacKenzie, Director of CVS’ Practice Division, said: "Severn Edge is an impressive practice with an outstanding leadership team and an ambitious and exciting vision for the future which we share. We are delighted to welcome the team to CVS and look forward to working with them to help them build an even more successful future."
Dr John Brentnall BVSc MRCVS, a Director of Severn Edge, will continue in the role of CVS Regional Director. He said: "It was clear from our early discussions that CVS understood what we are trying to achieve. We have embarked on a significant investment programme, including upgrading our surgery at Madeley outside Telford, and the redevelopment of the site of an additional clinic which we have recently acquired in Craven Arms.
"In order for us to continually upgrade our clinics, provide the widest range of career opportunities for our staff and steer our practice through an increasingly competitive world, we believe that the best interests of us all lie in joining forces with CVS. It is known for its interest in equine and farm practice, as well as companion animal practice, and has a policy of significant investment in both infrastructure and staff. We believe it offers the best fit with Severn Edge."
In current regional anaesthesia procedures two operators are often needed, with an assistant using 'feel' to inject the anaesthetic solution at the required pressure. This, says the company, means anaesthetic solutions can be injected at unsafe pressures. The new device incorporates a safety system that limits injection pressure, to reduce the risk of nerve injury.
Dr. Federico Corletto, Consultant Anaesthetist from Dick White Referrals said: “By turning regional anaesthesia into a one-person procedure, the technology also removes the challenges of communicating with an assistant regarding subjective injective pressure feel, thus removing the unpredictability of an untrained hand.”
Medovate says the use of ultrasound guided regional anaesthesia is becoming more common practice today, with the technique – which can help provide a higher level of visualisation for the practitioner – increasingly seen as a ‘gold standard’.
However, there are limitations and challenges that are not always present in the practice of adult human medicine. Nerve parathesia, for instance, is harder to ascertain in animals. Small animals such as cats also have increased sensitivity to local anaesthetics when compared with other species, necessitating much lower maximum doses be used.1
Brett Hughes, Homecare & Veterinary Business Manager at Vygon UK, said: "The device infuses at 0.5ml/second, and to vets the technology offers a valuable tool that can control injection small intervals at a time. This allows the veterinary practitioner to titrate appropriately to see the anaesthesia spread around a nerve bundle.
"There are a significant number of regional anaesthesia blocks completed in veterinary practice per annum globally, so potentially this NHS developed device could play a major role in the future of veterinary practice."
For more information, visit: https://www.medovate.co.uk/veterinary/safira-for-veterinary-applications and https://www.vygonvet.co.uk/
Reference
Maprelin, which contains a new active molecule, Peforelin, is a gonadotropin releasing hormone (GnRH). A single, low volume injection of the ready-to-use solution induces oestrus in sows after weaning, and in sexually mature gilts where oestrus has been synchronised with Regumate Porcine.
According to the company, it works by selectively inducing the release of the animal's own follicle stimulating hormone (FSH), leading to follicle growth - critical to successful reproduction - and the stimulation of oestrus. Conventional GnRHs, because of their mode of action, are used mainly to induce ovulation.
Janssen says Maprelin is the next step in its pig reproduction programme, named Syncoris. Cornerstone of this programme is Regumate for gilt synchronisation.
Trials have shown that with the use of Maprelin (compared with control groups of breeding animals) the number of gilts and sows showing oestrus within six days of treatment increased by about 15 percentage points (Table 1). For first-litter sows the figure was more than 8 percentage points. The duration of oestrus was not affected.
Gilts came on heat two days faster than with Regumate alone, and the weaning to oestrus interval with sows achieved similar statistically significant reductions.
Farrowing rate increased by over 5 per cent for sows, by 6 per cent for first-litter sows and just on 8 per cent for gilts.
Added to those benefits, for each 100 inseminations sows produced an extra 104 piglets, first-litter sows 105 and gilts an even more impressive 158. All gilt groups in the trials, including the control groups, were synchronised with Regumate. With unsynchronised gilts it is not possible to predict the correct time to inject Maprelin.
Phil Macdonald, the company's UK pig and poultry business manager, says the objective of every producer is profitable pigmeat production. "In the UK and other EU states the costs of feed, housing and labour are considerably higher than in other major pig-producing sectors of the world.
"This makes it important for UK producers to optimise management of the reproductive process. Maprelin is a valuable tool that can help with this objective."
The precision injection gun with Maprelin enables accurate delivery of the small amounts required. Gilts require a 2.0 ml dose 48 hours after their last Regumate treatment, first-litter sows a 0.5 ml dose 24 hours after weaning and multi-litter sows 2.0 ml 24 hours after weaning. Injections are intramuscular.
The solution requires no mixing, reducing the possibility for errors. Opened vials have a shelf life of 28 days and unopened vials a shelf life of two years. Sows and gilts need only one injection per parity, and the withdrawal period for meat and offal is zero days.
Lots of April Fool's Day gags involving animals this year...
watch?v=1kC0OI9MYZc
The Sun reported that Sir Richard Branson's health club chain, Virgin Active, is launching a new gym for dogs only, to combat the pet obesity epidemic. Alton Towers supposedly launched a new rollercoaster ride for dogs only. Meanwhile, Pasante, a condom manufacturer, launched the 'condog', though this seems to be a variation on an idea that has been around for a while now.
My favourites, though, were two April fools unrelated to animals. The first was from Cadbury's, made more believable by the fact that it was planted in the Southampton Echo. The second was the announcement by BMW that Dr. Noit All, the company's Head of Innovation, had developed a fuel-saving system called Magnetic Tow Technology (MTT). Readers were invited to keep abreast with future developments from BMW by emailing Dr. Noit All's colleague at uve.vollenvorit@bmw.co.uk.
The AWF funds research, supports veterinary education, provides pet care advice and encourages debate on animal welfare issues.
AWF trustees are responsible for facilitating the achievement of the charity’s mission, providing strategic direction and safeguarding AWF’s brand and reputation.
The charity is now inviting applications from veterinary professionals with current or recent experience in production animal practice.
Trustees are expected to attend at least two meetings a year during their three-year term, as well as AWF’s annual flagship event in Westminster, the AWF Discussion Forum. They are also encouraged to engage with one or more of AWF’s Sub Committees focussing on particular areas of the charity’s activity, such as grant making and public education.
AWF Trustee Nicola Martin said: "Being an AWF Trustee gives you a fantastic opportunity to work on a wide range of welfare issues facing a variety of species rather than just those in your area of expertise. I enjoy discussing and debating issues, sharing my views and understanding those of others, as well as having the chance to shape the future of this great charity."
Simon Doherty, BVA Junior Vice President and AWF Trustee, said: "As a vet with a long-standing interest in research that provides an evidence base for animal welfare policy decisions, my involvement with AWF has given me the opportunity to promote research not only within my specialist fields of livestock and aquaculture but also learn more about welfare research in the companion animal sector.
"AWF does excellent work in engaging members of the public and the profession with crucial animal welfare topics, so I’d urge my colleagues to apply as Trustees to help direct the charity’s work in the future."
The deadline for AWF Trustee applications is 9am on 20 August 2018. For more information, visit: https://www.animalwelfarefoundation.org.uk/about-us/become-a-trustee/
Equip Artervac is indicated for the active immunisation for horses against equine arteritis virus to reduce the clinical signs and shedding of virus in nasal secretions following infection.
Zoetis says it is working hard to resolve the situation and apologises for any convenience caused.
For more information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.
To enter the competition, which will run during National Pet Dental Health Month in February, you need to share a picture of a dog or cat having its teeth brushed during a consultation or share a tip to make it easier for owners and pets to enjoy dental care at home.
The first 100 entries in each category will receive 10 finger brushes for their clinic, with Ceva’s favourite top five pictures and tips winning £50 Love2shop vouchers.
To share your photograph or tip, email it with your practice name and address to cevauk@ceva.com, post it on the Logic for Pets Facebook page or enter using the form on www.logicforpets.co.uk.
Make sure you have the owner’s permission before posting pictures. The competition closes on 1st March 2019.
Incidentally, Ceva provides free Logic samples to veterinary practices to offer to clients; contact your local Ceva territory manager or email cevauk@ceva.com for more information.
The RCVS Disciplinary Committee has dismissed a case against Duncan Davidson MRCVS, a South London veterinary surgeon accused of clinical failings in relation to his treatment of a cat and of keeping poor and misleading clinical records.
The Committee heard the case against Dr Davidson, who was the sole practitioner and owner of Mitcham Veterinary Clinic until his retirement from clinical practice in November 2014, at a hearing which concluded on 22nd January.
The first charge against Dr Davidson alleged that, between 7 November 2013 and 13 December 2013, he had failed to provide adequate care to Ameira, an Egyptian Mau cat. The charge was in four parts: that he had inappropriately administered corticosteroids; had failed to administer adequate fluid therapy; discharged the cat to its owner suggesting a referral when he should have suggested or arranged a same-day referral; and that he failed to communicate the urgency of referral/ further investigation of the cat’s condition to her owner.
The second charge was that, between 7 November 2013 and 17 January 2014, he dishonestly made retrospective alterations to Ameira’s clinical records and failed to keep clear, accurate and detailed clinical records.
From the outset Dr Davidson, who attended the hearing, did not admit the charges against him and denied that his conduct, if found proven, constituted serious professional misconduct.
A summary of the circumstances of the case were that the cat had been admitted to Dr Davidson’s practice on 8 November 2013 with poor appetite and a piece of thread in its mouth. The cat was later admitted, on 21 November, with dehydration and was diagnosed with a linear foreign body (ie the thread) on 25 November 2013. Dr Davidson continued to treat Ameira with corticosteroids and rehydration fluids at the practice but a second opinion was sought by Ameira’s owner from a nearby veterinary practice. This practice referred the cat to the Royal Veterinary College for treatment. Surgery to remove the linear foreign body was undertaken on 13 December 2013, albeit with a poor prognosis, and Ameira subsequently suffered two cardiac arrests and died on 14 December 2013.
In terms of its findings on the first charge, the Committee heard from an expert witness, Mr Hurst, regarding the use of the corticosteroids which were administered to the cat by Dr Davidson on 22, 27 and 30 November 2013 and 5 and 12 December 2013. Although Mr Hurst said that a minority of veterinary surgeons may have provided corticosteroids when the cat was first presented to Dr Davidson on 8 November; when it was determined by Dr Davidson’s colleague Mr Holden that the cat’s condition was due to it having ingested thread, the use of corticosteroids was inappropriate from then on and would be considered contra-indicated. The Committee found this charge proven.
The Committee did not find the charge against Dr Davidson that he failed to provide adequate fluid therapy proven. When the cat was presented to the practice on 21 November 2013 suffering from dehydration, fluid rehydration was given but not administered intravenously. The Committee concluded that intravenous hydration was not necessary because the clinical records from both Dr Davidson and the Royal Veterinary College indicated that Ameira was only moderately dehydrated.
Regarding the referral of Ameira, the Committee could not be sure that the cat was sufficiently unwell on 23 November that it required immediate referral. Dr Davidson had sent Ameira home with her owner on that date on the basis that she was stable and that he would arrange a referral for her on 25 November. There was conflicting evidence from Dr Davidson and Ameira’s owner on the matter of whether, on 23 November, Ameira’s owner was advised that the cat’s condition was critical or that a referral was urgently required. Dr Davidson accepted that he did not seek to make an urgent referral. The charge was not proven.
Regarding the communication of the urgency for further investigation of Ameira’s condition, the Committee found that there was insufficient evidence to suggest that Dr Davidson did not adequately communicate with Ameira’s owner after the diagnosis of a linear foreign body was made on 25 November. According to Dr Davidson, he explained the risk of further damage to the oesophageal and gastrointestinal tract and offered further radiography. This was strongly contested by Ameira’s owner. However, ultimately the Committee were unable to be satisfied as to which version was correct to the necessary standard of proof required.
Regarding the retrospective amendment of clinical records, the Committee found that although there were some “troubling aspects” about the case, particularly evidence of a telephone call with the RCVS Professional Conduct Department in which Dr Davidson said that no retrospective alterations had been made, it was unable to be satisfied so as to be sure of his motivation for changing the records. His contention was that changes had been made as he was concerned he would be subject to civil litigation by Ameira’s owner. However, the Committee found the charge not proven, also taking into account Dr Davidson’s good character and unblemished professional record over 40 years.
However, the Committee did find that Dr Davidson’s clinical records were illegible. Dr Davidson recognised the poor quality of his handwriting, which the veterinary surgeons to whom Ameira was referred were unable to understand. The Committee found this charge proven.
Taking into account the charges it found proven, the Committee then considered whether they constituted serious professional conduct either individually or cumulatively. Judith Webb, who chaired the Committee and spoke on its behalf, said: "It does not consider that on the facts of this case the administration of corticosteroids amounted to disgraceful misconduct."
She added: "The Committee has already emphasised the importance of making legible handwritten records but it does not consider that the failure to do so in this case amounts to disgraceful misconduct.... The Committee has found that Dr Davidson was wrong to make retrospective entries in this case without making it clear when such alterations were made. The Committee does not consider that in this case the making of those alterations was capable of being disgraceful misconduct. The case is dismissed."
The guidelines are designed to support veterinary surgeons, veterinary nurses and wildlife rehabilitators, in order to promote and achieve the best possible care and welfare for indigenous British wild animals in accordance with UK law.
The Society says that guidelines are needed because:
Mark Stidworthy, BVZS President (pictured above right), said: "The rescue and rehabilitation of wildlife by veterinary surgeons and wildlife professionals is highly valued by the British public, making a positive contribution to local communities, the health and welfare of individual animals and to conservation. We hope these guidelines will inform best practice in this area and ensure its continued success."
Theresa Amory, Chair of the British Wildlife Rehabilitation Council (BWRC) said: "BWRC aims to support and promote the professional integrity of wildlife rehabilitators. While we recognise that meeting all of these guidelines may be difficult (particularly for smaller scale rehabilitators) we hope that they will enable rehabilitators to work alongside veterinary partners with increased awareness and confidence in their own working policies and procedures."
Michael Stanford, BVZS Senior Vice President, Veterinary Defence Society Claims Consultant said: "The BVZS Wildlife Guidelines should ensure all stakeholders involved with wildlife rehabilitation are acting in the best interests of animal welfare, with the added reassurance that they are acting in accordance with UK law."
Liz Mullineaux, veterinary surgeon and one of the authors of the guidelines said: "Working with British wildlife has always been challenging, for both vets and rehabilitators, in terms of what is ethical, legal and of an adequate clinical standard. These guidelines clarify many of those things, describing best practice and achievable standards for this area of work."
The guidelines can be downloaded from: http://www.bvzs.org/images/uploads/BVZS_Good_Practice_Guidelines_for_Wildlife_Centres_011016_.pdf
Pfizer has divested itself of its animal health business unit, which has become a stand-alone company called Zoetis. The new company unveiled its vision for Europe, Africa and the Middle East (EuAfME) region at a press conference in Paris last week.
The company says it aims to have its products, services and people as the most valued by animal health customers around the region, and the world.
Alejandro Bernal, Zoetis Executive Vice President and Area President for the EuAfME region said: "We are united around this shared vision, and we strive every day to help customers meet their real-world challenges through quality medicines and vaccines, complemented by diagnostic products, genetic tests and a range of services," said "As the largest standalone company in the industry, we are dedicated solely to animal health and focusing on our core business so our customers can grow theirs."
In addition to working closely with customers, Zoetis said it strives to collaborate with universities and other research organisations, to help advance the animal health sector and those who raise and care for animals. One example of this is the partnership with the University of Stirling, one of the leading research organisations, based in Scotland.
Professor Randolph Richards, from Stirling said: "Academia is increasingly realising the benefits of working with industry on research projects, and is concentrating on those with more direct impact rather than on pure research. In our own case, Zoetis has been able to provide resources which were otherwise unavailable to us, with funding opportunity being provided through the UK Technology Strategy Board."
James Hutchings, Head of Sales for Bimeda UK, said: "The launch of Tetroxy Vet highlights our ongoing commitment to providing UK veterinarians with a choice of high quality veterinary pharmaceuticals at a fair price."
Bimeda says the benefits of Tetroxy Vet include:
Tetroxy Vet is available in a 100ml pack size.
The tips, put together by Tessa Plagis (communication advisor at St. Anna Advies), Alan Robinson (director of VetDynamics) and Rebecca Robinson (coach at VetDynamics and senior clinician in veterinary anaesthesia at the AHT), are being shared to set the scene for Congress 2023, where international experts will be exploring how time management at organisational, systems, teams and an individual levels can lead to drastic improvements in performance, job satisfaction and wellbeing.
The Association points to the demands on the profession caused by the fact that veterinary professionals have been saying 'yes' to everything for years: yes to more clients, more patients and more overtime.
This, says BSAVA, is taking its toll: experienced practitioners and recent graduates are leaving the profession, and many more are suffering mental and physical health issues associated with sustained high stress.
Tessa Plagis, communication advisor at St. Anna Advies, said: “We are at a tipping point and can’t keep doing what we’ve always done. If we want sustainable veterinary businesses going forward we need to change the structure of how we work.”
Tessa says the issues are both organisational and individual: “Many veterinary professionals struggle to give boundaries.
"We are people pleasers and tend to say ‘yes’, even if that means compromising other important aspects of lives, such as family.
"This set against a background of too few vets, which means that there’s nobody to help us out when there’s too much to-do.”
To find out more about time management, book your ticket for BSAVA Congress at: https://www.bsavaevents.com/bsavacongress2023/en/page/home, and in the meantime, here are Tessa, Alan and Rebecca's time management tips.
Tessa's tips
Alan's tips
Rebecca's tips
The recording of the VPMA’s GDPR webinar with the Information Commissioner's Office has been made available to the veterinary profession to help practices get ready for the 25th May 2018, when the new regulations come into force.
For access to the webinar, email: secretariat@vpma.co.uk
David Chalkley MRCVS faces four alleged charges:
At the start of the hearing Mr Chalkley made no admissions as to the charges but he had made an application for an adjournment based on undertakings to remove himself from the Register and never to apply to be restored to the Register.
In addressing the Committee on behalf of Mr Chalkley, his counsel said that Mr Chalkley denied all charges of dishonesty, that there was no evidence of harm to animals as a result of the alleged conduct, that there had been no complaint from the client and that he had repaid all the sums he had received for tuberculin testing on the farm in question.
His counsel also submitted that a full hearing would be expensive and time-consuming, and that it would serve no useful purpose as animal welfare and the protection of the public would be served by Mr Chalkley’s proposed undertakings.
Counsel on behalf of the RCVS confirmed that the College did not oppose the application and confirmed that the Animal Plant and Health Agency did not object.
However, the Disciplinary Committee concluded that because the case concerned issues of alleged dishonesty in veterinary certification over a prolonged period of time and the importance of public trust in the accuracy and reliability of that process, there was a need to hold a full, public hearing into Mr Chalkley’s alleged conduct.
Ian Arundale, chairing the Committee and speaking on its behalf, said: “The Committee expressed no view as to whether the allegations could be substantiated or not and it recognised that the process of determining the allegations would be burdensome for many, particularly the respondent.
"It was satisfied, however, that a reasonable and fully informed member of the public would be disturbed to learn that allegations of this kind had not been the subject of a formal determination by the Disciplinary Committee. The respondent’s own interests had to take second place to this important public interest.
“The Committee therefore declined to accept the application to adjourn this inquiry [until an unspecified date] and directed that arrangements should now be considered for the listing of a hearing in this case.”
It is expected that the full hearing will take place in spring 2021.
Instead of conducting major open surgery, Chris Shales, an RCVS and European Specialist in Small Animal Surgery, Andrew Kent, a European Specialist in Internal Medicine, and the cardiology team at Willows are using coil embolization, a minimally invasive technique which they say is far safer and less likely to lead to post-operative complications.
The procedure involves threading tiny coils, via the jugular vein, through the venous system and positioning them in the blood vessel that needs to be closed. The coils encourage the blood to form a clot and so, over time, seal the vein.
Chris said: "This procedure of treating intrahepatic portosystemic shunts is associated with a lower risk of mortality and a lower surgical morbidity rate when comparted to open surgery. The overall outcome of the two approaches is similar in terms of reduction of flow through the shunt vessel.
"Access is gained via a small incision in the neck to allow the team to operate on the liver via the jugular vein using fluoroscopy to visualise the placement of a stent within the vena cava and embolization coils within the abnormal vessel.
"Intrahepatic shunts can be extremely challenging for the surgical team to access with the result that standard, open surgical treatment of these abnormal vessels can risk life-threatening complications and animals can require a significant time to recover."
For more information about shunt surgery at Willows, contact Chris Shales or Small Animal Internal Medicine Specialist Andrew Kent on 0121 712 7070 or email enquiries@willows.uk.net.
Photo: Chris Shales, left, with Andrew Kent, centre, and cardiologist Mike Martin ('pass me a gin and tonic, would you').
In previous years, candidates were only asked to provide manifestos, which often contained information that wasn't especially relevant to whether or not they should be elected to Council.
Now, they are asked to share their reasons for wanting to be elected, what they can bring to Council and what experience they have.
That should make it much easier for voters to pick the right candidates, which is no bad thing because there are 20 vets standing this year, a record since electronic records began in 1997 and 1 more than the previous best in 2014.
This year’s candidates are:
Louise Allum MRCVSSam Bescoby MRCVSAndrew Clemence MRCVSTshidi Gardiner MRCVSReginald Godwin MRCVSPaddy Gordon MRCVS Danielle Greenberg MRCVSGerard Henry MRCVSRichard Hillman MRCVSBenjamin Kennedy MRCVSDarren Partridge MRCVSMartin Peaty MRCVSAlison Price MRCVSPeter Robinson MRCVSJennifer Simmons MRCVSSadie Spencer MRCVS Mary Thomas MRCVSWilliam Wilkinson MRCVSLara Wilson MRCVS
and the inevitable Tom Lonsdale MRCVS.
The full biographies and election statements for each candidate are available to read at www.rcvs.org.uk/vetvote25.
The four candidates who get the most votes will take up their four-year terms on RCVS Council at the College’s Annual General Meeting on Friday 4 July 2025.
Simon Wiklund, Assistant Registrar and Returning Officer for both elections, said: “We are glad to see such a large number of veterinary professionals putting themselves forward as candidates for this year’s elections.
"It is worth noting that any future governance changes, including RCVS and VN Councils becoming all-appointed bodies, are contingent on new legislation and, until that happens, we will continue to hold our annual elections.
“You may have also noticed some differences with this year’s elections, particularly in terms of the candidate statements.
"This is thanks to a change to our election scheme, which provides greater flexibility about how we run our elections, and the information that we can ask the candidates to submit.
“This means that, rather than asking candidates for a broad manifesto statement, we’ve asked them to answer key questions that are relevant to the role of a Council member, including what skills and experiences they can bring to the table.”
Ahead of the elections, RCVS will be running its ‘Quiz the candidates’ initiative in which veterinary surgeons can submit questions to the candidates standing in their respective elections, in order to better understand them and their views.
However, due to the additional information now included in each of their statements, this year candidates will only answer one question of their choice each.
Before submitting questions to the candidates, please note the RCVS will only accept one question per person. Offensive, defamatory and inaccurate questions will be rejected by the Returning Officer and not be passed on to candidates.
Veterinary surgeons can submit a question to the RCVS Council candidates by emailing vetvote25@rcvs.org.uk.
Furosoral contains furosemide and is indicated for the treatment of hydrothorax, hydropericardium, ascites and oedema, particularly in animals where these conditions are associated with cardiac insufficiency and renal dysfunction.
Furosoral replaces Dechra’s previous diuretic treatment, Frusedale.
It is available in both 10 mg and 40 mg double-divisable tablets.
The recommended daily starting dose for cats and dogs is 2.5 mg per kg of body weight.
Dechra says careful weighing is essential to ensure accurate dosing, but that the dosage can be doubled initially for severe or particularly resistant cases and adjusted to the lowest clinically effective dose for maintenance therapy if required.
Dechra companion animal brand manager, Charlotte Hill, said: “Furosoral offers a flexible treatment solution where dosage can be adjusted, depending on the needs of the patient and the underlying causes, to give vets more options for treating cats and dogs with fluid retention.
“To ensure it is as appealing to pet owners as it is to veterinary professionals, Furosoral is available in our innovative Smart Tab format, giving owners confidence that they are giving their dog or cat the right dosage and aiding compliance, leading to better outcomes for the animal.”
Furosoral 10 mg and 40 mg tablets are available in blister packs of 100 tablets for quick and easy dispensing. Divided tablets can be stored in the blister pack for up to three days, ensuring no waste.
https://www.dechra.co.uk/products/dog/prescription#/search=furosoral/.
Ceva Animal Health has added to its joint care range with the launch of Meloxidyl Oral Suspension for Cats, licensed for the treatment of musculoskeletal disorders and alleviation of post-operative pain.
Meloxidyl Oral Suspension for Cats is available in 15ml bottles containing 0.5mg/ml meloxicam. Each pack contains a tailored maintenance dosing syringe with a 'kg scale' for all sizes of cat. In addition, Meloxidyl's sweet tasting formulation helps to maximise ease of administration.
Meloxidyl Injection complements Ceva Animal Health's joint care range, which also includes Meloxidyl Injection for dogs and cats and Meloxidyl Oral Suspension for dogs.
For further information, please contact your Ceva Animal Health representative or call 01494 781510.
Ceva says this is the first time it has advertised Feliway Friends - designed to help cats live together in harmony - on television. It will be rotating the Feliway advert with one explaining the benefits of the Adaptil Calm On-the-Go Collar.
Both advertisements are 30 seconds long and the campaign runs until the end of June. It will target 24.5 million pet owners and will air on all Channel 4 and Channel 4 partner channels, including Channel 4, E4, More4, Film4, Drama, Good Food, Really, W and Home.
Abigail King, product manager for Feliway and Adaptil at Ceva, said: "Our summer TV advertising campaign will raise awareness of how Feliway Friends and Adaptil Calm On-the-Go Collar can help pets with behavioural issues and drive customers to veterinary practices for further information and to purchase product."
For further information, visit www.feliway.com or www.adaptil.com.
Cognitive aids are visual prompts that aim to reduce human error in critical processes by providing a supportive framework that ensures tasks are performed and communicated appropriately. They are designed for use whilst a task is being undertaken and enable individuals to concentrate on problem-solving and decision-making.
The BSAVA Cognitive Aids for Anaesthesia in Small Animal Practice, written by veterinary anaesthesia specialist Matt McMillan, includes both routine checklists, such as pre-anaesthetic assessment, equipment checks and postoperative handover, and crisis checklists for potential complications that may be encountered during surgery, such as hypotension, bradycardia and haemorrhage.
The guide also includes downloadable forms, which can be used in practice to ensure safety checks are completed and help improve clinical outcomes (available from www.bsavalibrary.com).
Ian Self, Principal Clinical Anaesthetist at the University of Cambridge Department for Veterinary Medicine said: "This handbook should be viewed as a ‘second pair of eyes’ throughout a procedure, especially if an anaesthetised patient deteriorates; consider it as having an experienced anaesthetist looking over your shoulder offering words of advice… I am very happy to endorse this exciting new BSAVA resource."
The BSAVA Cognitive Aids for Anaesthesia in Small Animal Practice is now available from the BSAVA website (www.bsava.com/shop) or by phone on 01452 726700 (£25; BSAVA members: £15).
Virbac says HCA targets specific affected topical areas with negligible systemic absorption, to provide direct and rapid relief from inflammation and pruritus, delivering significant clinical improvement in atopic cases, both lesion and pruritus scores, after 14 days1.
Cortavance can be applied daily for up to 28 days and included within multimodal treatment plans for prolonged use to control atopy.
Cortavance is presented in a new ergonomic-shaped bottle allowing the user to accurately target the problem area at any angle, with its no-hand-contact spray applicators - 31ml and 76ml sizes.
For further information, contact your local Virbac Territory Manager.
Elanco Companion Animal Health has launched a new ordering process for Recuvyra, its transdermal fentanyl solution for the control of postoperative pain relief in dogs.
The new process will enable veterinary practices to purchase Recuvyra, which is a Schedule Two Controlled Drug, without having to complete the online training programme which was has been mandatory since the launch of the product in April 2013.
The company says that training is still highly recommended for every veterinary professional that handles Recuvyra due to its new delivery system. This can be via the short online training course available at www.recuvyratraining.eu or by reading the training leaflet provided with every vial of Recuvyra. The training leaflet includes information on instructions for use, correct administration of the product and special precautions. In addition, client leaflets and other support materials will continue to be available to vets via the website.
Alice Laurens, Recuvyra product manager at Elanco Companion Animal Health, said: "Veterinary practices will still need to follow their wholesalers' procedures for ordering Schedule Two Controlled Drugs when purchasing Recuvyra, however any vet from the practice can now order and sign for delivery of the product making it easier to purchase."
For further information about Recuvyra or Elanco's surgery and pain management range, contact your Elanco Companion Animal Health key account manager or email elancocah.uk@elanco.com.
Merial Animal Health has launched Veloxa, a palatable broad spectrum dewormer for dogs, effective against roundworm, hookworm, whipworm and tapeworm.
Merial says Veloxa uses a proprietary technology which coats the bitter active ingredients in the beef-flavoured chewable tablets. In the company's palatability tests it achieved 97% acceptance.
Veloxa tablets are scored for accurate dosing and come in two sizes:
Christine Male, Product Manager of Veloxa said: "Merial has a strong heritage in anti-parasitics and understands how difficult it can be for pet owners to administer worming tablets, so we are extremely pleased to be able to offer Veloxa as part of the Merial anti-parasitics range."
Dechra Veterinary Products has announced that Intubeaze Oromucosal Spray is now back in stock.
Intubeaze is used for local anaesthesia of the laryngeal mucosa of cats to facilitate endotracheal intubation by preventing the stimulation of the laryngeal reflex.
The product had gone out of stock due to a temporary manufacturing problem which has now been fixed.
Intubeaze is a clear solution containing 2% w/v lidocaine hydrochloride, with 0.1% w/v chlorocresol as an antimicrobial preservative. Intubeaze is now available through all wholesalers.
For further information on Intubeaze please contact Dechra on 01743 441 632 or visit www.dechra.co.uk.